Pine Bridge Investments, L.P. Avadel Pharmaceuticals PLC Transaction History

Pine Bridge Investments, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$8.48 - $16.48 $13,941 - $27,093	-1,644 Reduced 39.88%	2,478 $40,000
Q1 2023 May 12, 2023	SELL	$6.41 - $9.95 $20,428 - $31,710	-3,187 Reduced 43.6%	4,122 $37,000
Q2 2022 Aug 05, 2022	BUY	$1.07 - $6.95 $6,429 - $41,762	6,009 Added 462.23%	7,309 $18,000
Q1 2022 May 12, 2022	BUY	$5.46 - $8.29 $7,098 - $10,776	1,300 New	1,300 $9,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.